Biology and diagnosis of aberrant crypt foci

Colorectal Disease

Volumn 14, Issue 4, 2012, Pages

  Lopez Ceron, M ^a   Pellise, M ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Aberrant crypt foci; Biomarker; Carcinogenesis; Colorectal cancer

Indexed keywords

ABERRANT CRYPT FOCUS; CANCER DIAGNOSIS; CANCER RISK; CHROMOENDOSCOPY; CHROMOSOMAL INSTABILITY; COLONOSCOPY; COLORECTAL CANCER; CONFOCAL LASER MICROSCOPY; CPG ISLAND; DIAGNOSTIC ACCURACY; DYSPLASIA; ENDOCYTOSCOPY; EPIGENETICS; HUMAN; HYPERPLASIA; MEDLINE; MICROSATELLITE INSTABILITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

ABERRANT CRYPT FOCI; COLONOSCOPY; COLORECTAL NEOPLASMS; GENETIC MARKERS; HUMANS;

EID: 84857951718     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02925.x     Document Type: Review

References (63)

1. Cancer incidence in five continents. Volume IX, 2007. (Eds: Curado MP, Edwards B, Shin HR et al.) IARC Scientific Publications, Lyon.
2. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
3. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987; 37: 147-51.
4. McLellan EA, Bird RP. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res 1988; 48: 6187-92.
5. McLellan EA, Medline A, Bird RP. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res 1991; 51: 5270-4.
6. McLellan EA, Medline A, Bird RP. Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis 1991; 12: 2093-8.
7. McLellan EA, Bird RP. Specificity study to evaluate induction of aberrant crypts in murine colons. Cancer Res 1988; 48: 6183-6.
8. Bird RP, Good CK. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 2000; 113: 395-402.
9. Cho NL, Redston M, Zauber AG et al. Aberrant crypt foci in the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila Pa) 2008; 1: 21-31.
10. Mutch MG, Mph RE, Fleshman JW et al. A multi-center study of prevalence and risk factors for aberrant crypt foci. Clin Gastroenterol Hepatol 2009; 7: 568-74.
11. Schoen RE, Mutch M, Rall C et al. The natural history of aberrant crypt foci. Gastrointest Endosc 2008; 67: 1097-102.
12. Gupta AK, Pinsky P, Rall C et al. Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci. Gastrointest Endosc 2009; 70: 322-30.
13. Renehan AG, O'Dwyer ST, Haboubi NJ, Potten CS. Early cellular events in colorectal carcinogenesis. Colorectal Dis 2002; 4: 76-89.
14. Kristt D, Bryan K, Gal R. Colonic aberrant crypts may originate from impaired fissioning: relevance to increased risk of neoplasia. Hum Pathol 1999; 30: 1449-58.
15. Pinsky PF, Fleshman J, Mutch M et al. One year recurrence of aberrant crypt foci. Cancer Prev Res (Phila Pa) 2010; 3: 839-43.
16. IARC Working Group on the Evaluation of Cancer Preventive Agents. (1997) Non-Steroidal Antiinflammatory Drugs. IARC Press, Lyon.
17. Takayama T, Katsuki S, Takahashi Y et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998; 339: 1277-84.
18. Rudolph RE, Dominitz JA, Lampe JW et al. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans. Cancer Epidemiol Biomarkers Prev 2005; 14: 605-8.
19. Moxon D, Raza M, Kenney R et al. Relationship of aging and tobacco use with the development of aberrant crypt foci in a predominantly African-American population. Clin Gastroenterol Hepatol 2005; 3: 271-8.
20. Shpitz B, Klein E, Buklan G et al. Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer. Gut 2003; 52: 1598-601.
21. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001; 10: 725-31.
22. Anderson JC, Pleau DC, Rajan TV et al. Increased frequency of serrated aberrant crypt foci among smokers. Am J Gastroenterol 2010; 105: 1648-54.
23. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002; 31: 925-43.
24. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 2001; 85: 1700-5.
25. Roncucci L, Stamp D, Medline A, Cullen JB, Bruce WR. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 1991; 22: 287-94.
26. Hamilton SR, Aaltonen LA. (Eds.) World Health Organization classification of tumours. pathology and genetics of tumours of the digestive system 2000, IARC Press, Lyon.
27. Paulsen JE, Namork E, Steffensen IL, Eide TJ, Alexander J. Identification and quantification of aberrant crypt foci in the colon of Min mice - a murine model of familial adenomatous polyposis. Scand J Gastroenterol 2000; 35: 534-9.
28. Hurlstone DP, Karajeh M, Sanders DS, Drew SK, Cross SS. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia. Am J Gastroenterol 2005; 100: 1283-9.
29. Pretlow TP, Pretlow TG. Mutant KRAS in aberrant crypt foci (ACFs): initiation of colorectal cancer? Biochim Biophys Acta 2005; 1756: 83-96.
30. Suehiro Y, Hinoda Y. Genetic and epigenetic changes in aberrant crypt foci and serrated polyps. Cancer Sci 2008; 99: 1071-6.
31. Siu IM, Pretlow TG, Amini SB, Pretlow TP. Identification of dysplasia in human colonic aberrant crypt foci. Am J Pathol 1997; 150: 1805-13.
32. Otori K, Sugiyama K, Hasebe T, Fukushima S, Esumi H. Emergence of adenomatous aberrant crypt foci (ACFs) from hyperplastic ACFs with concomitant increase in cell proliferation. Cancer Res 1995; 55: 4743-6.
33. Yokota T, Sugano K, Kondo H et al. Detection of aberrant crypt foci by magnifying colonoscopy. Gastrointest Endosc 1997; 46: 61-5.
34. Levine JB, Grupka M, Parente M. Narrow band imaging close focus colonoscopy detection of colon aberrant crypt foci. Gastrointest Endosc 2006; 63: AB243.
35. Cipolletta L, Bianco MA, Rotondano G et al. Endocytoscopy can identify dysplasia in aberrant crypt foci of the colorectum: a prospective in vivo study. Endoscopy 2009; 41: 129-32.
36. Sanduleanu S, Driessen A, Gomez-Garcia E, Hameeteman W, de Bruïne A, Masclee A. In vivo diagnosis and classification of colorectal neoplasia by chromoendoscopy-guided confocal laser endomicroscopy. Clin Gastroenterol Hepatol 2010; 8: 371-8.
37. Shpitz B, Bomstein Y, Mekori Y et al. Aberrant crypt foci in human colons: distribution and histomorphologic characteristics. Hum Pathol 1998; 29: 469-75.
38. Kim J, Ng J, Arozulllah A et al. Aberrant crypt focus size predicts distal polyp histopathology. Cancer Epidemiol Biomarkers Prev 2008; 17: 1155-62.
39. Adler DG, Gostout CJ, Sorbi D, Burgart LJ, Wang L, Harmsen WS. Endoscopic identification and quantification of aberrant crypt foci in the human colon. Gastrointest Endosc 2002; 56: 657-62.
40. Seike K, Koda K, Oda K et al. Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms. Am J Gastroenterol 2006; 101: 1362-9.
41. Stevens RG, Swede H, Heinen CD et al. Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer. Cancer Lett 2007; 248: 262-8.
42. Bouzourene H, Chaubert P, Seelentag W, Bosman FT, Saraga E. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease. Hum Pathol 1999; 30: 66-71.
43. Roncucci L, Modica S, Pedroni M et al. Aberrant crypt foci in patients with colorectal cancer. Br J Cancer 1998; 77: 2343-8.
44. Takayama T, Ohi M, Hayashi T et al. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 2001; 121: 599-611.
45. Roncucci L, Medline A, Bruce WR. Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol Biomarkers Prev 1991; 1: 57-60.
46. Siu IM, Robinson DR, Schwartz S et al. The identification of monoclonality in human aberrant crypt foci. Cancer Res 1999; 59: 63-6.
47. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology 1995; 108: 434-40.
48. Beach R, Chan AO, Wu TT et al. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol 2005; 166: 1069-75.
49. Shivapurkar N, Huang L, Ruggeri B et al. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients. Cancer Lett 1997; 115: 39-46.
50. Sakurazawa N, Tanaka N, Onda M, Esumi H. Instability of X chromosome methylation in aberrant crypt foci of the human colon. Cancer Res 2000; 60: 3165-9.
51. Smith AJ, Stern HS, Penner M et al. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 1994; 54: 5527-30.
52. Otori K, Konishi M, Sugiyama K et al. Infrequent somatic mutation of the adenomatous polyposis coli gene in aberrant crypt foci of human colon tissue. Cancer 1998; 83: 896-900.
53. Jen J, Powell SM, Papadopoulos N et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994; 54: 5523-6.
54. Mi B, Wang X, Bai Y et al. Beta-catenin expression is altered in dysplastic and nondysplastic aberrant crypt foci of human colon. Appl Immunohistochem Mol Morphol 2009; 17: 294-300.
55. Hao XP, Pretlow TG, Rao JS, Pretlow TP. Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res 2001; 61: 8085-8.
56. Pedroni M, Sala E, Scarselli A et al. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res 2001; 61: 896-9.
57. Heinen CD, Shivapurkar N, Tang Z, Groden J, Alabaster O. Microsatellite instability in aberrant crypt foci from human colons. Cancer Res 1996; 56: 5339-41.
58. Luo L, Shen GQ, Stiffler KA, Wang QK, Pretlow TG, Pretlow TP. Loss of heterozygosity in human aberrant crypt foci (ACFs), a putative precursor of colon cancer. Carcinogenesis 2006; 27: 1153-9.
59. Greenspan EJ, Cyr JL, Pleau DC et al. Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer. Carcinogenesis 2007; 28: 769-76.
60. Chan AO, Broaddus RR, Houlihan PS, Issa JP, Hamilton SR, Rashid A. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 2002; 160: 1823-30.
61. Zhu D, Keohavong P, Finkelstein SD et al. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients. Cancer Res 1997; 57: 2485-92.
62. Rosenberg DW, Yang S, Pleau DC et al. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res 2007; 67: 3551-4.
63. Lance P, Hamilton SR. Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention. Cancer Prev Res (Phila Pa) 2008; 1: 4-8.